Important note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.
Mail & Guardian Online - September 19, 2007
David Jackson
To date, the partnership has supported the development of laboratory capacity to test and monitor patient response to treatment. Information technology systems are being developed to track patient adherence. A didactic training course gives all healthcare professionals in Botswana the opportunity to enhance their knowledge of HIV/Aids clinical care, while more than 3 200 healthcare workers have received hands-on, clinic-based training from international Aids experts through a clinical preceptorships programe. Recent studies have shown that the rate of new infections appears to be declining. Between 2003 and 2005, the prevalence among 15 to 19-year-olds has declined by 22%, and the percentage of HIV-positive infants born to HIV-positive mothers from an estimated 40% at inception of the programme to about 6%.
Sam Nkalashe, corporate responsibility manager for MSD in South Africa, said: "Our commitment to health in Africa brought us to the Pan African Health Congress to interact with other players and concerned individuals and organisations to share ideas and move the agenda of a continent free of curable disease to meet the millennium goals." "Merck & Co has long been involved in efforts to expand access to medicines, vaccines and quality healthcare in the developing world. Among other activities, we are active participants in programmes to help build local healthcare capacity in Africa and elsewhere around the world. "Based on the lessons that we learned in previous HIV/Aids initiatives, we have also set up public-private partnerships to mobilise communities against HIV/Aids, change their behaviours and reduce HIV-related stigma." MSD has developed a Blueprint for Business Action against HIV/Aids. This simple and user-friendly tool, designed by an editorial board composed of African HIV/Aids experts, provides guidelines for small and medium-sized companies to implement a comprehensive HIV/Aids workplace programme.
070919
MG070904
Copyright © 2007 - Daily Mail & Guardian. For information about the content or for permission to redistribute, publish or use for broadcast, contact the publisher.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .